Medable, Pluto Health Strike Enterprise Partnership
Collaboration to focus on accelerating clinical development and increase access to research.
Medable Inc. announced in a company press release that it has formed a partnership with Pluto Health, a smart care coordination services company. Combining Pluto Health’s health coordination platform and Medable’s digitally enabled clinical trials platform, the joint venture aims to providing patients with greater control and the ability to share their health data directly into clinical trials through a seamless integration.
“Our partnership is primarily a win for patients, alongside other stakeholders, who will benefit from ongoing enhanced support,” said Joy Bhosai, MD, PhD, CEO, founder, Pluto Health, in a company press release. “Pluto is passionate about improving patient care in communities and designing systems that deliver resources for patients to manage health needs over time, especially if they are going through a clinical trial as part of a care option. We are excited for what the future holds with Medable.”
Reference: Medable Partners with Pluto Health to Optimize Patient Experience and Improve Access to Clinical Trials. Business Wire. October 3, 2023. Accessed October 3, 2023. https://www.businesswire.com/news/home/20231003413736/en/Medable-Partners-with-Pluto-Health-to-Optimize-Patient-Experience-and-Improve-Access-to-Clinical-Trials
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
